Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Scand J Gastroenterol ; 44(1): 85-92, 2009.
Article in English | MEDLINE | ID: mdl-18821132

ABSTRACT

OBJECTIVE: To evaluate whether there is any appreciable difference in imaging characteristics between high-resolution magnification white-light endoscopy (WLE-Z) and narrow-band imaging (NBI-Z) in Barrett's oesophagus (BE) and if this translates into superior prediction of histology. MATERIAL AND METHODS: This was a prospective single-centre study involving 21 patients (75 areas, corresponding NBI-Z and WLE-Z images) with BE. Mucosal patterns (pit pattern and microvascular morphology) were evaluated for their image quality on a visual analogue scale (VAS) of 1-10 by five expert endoscopists. The endoscopists then predicted mucosal morphology based on four subtypes which can be visualized in BE. Type A: round pits, regular microvasculature; type B: villous/ridge pits, regular microvasculature; type C: absent pits, regular microvasculature; type D: distorted pits, irregular microvasculature. The sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) and accuracy (Acc) were then compared with the final histopathological analysis and the interobserver variability calculated. RESULTS: The overall pit and microvasculature quality was significantly higher for NBI-Z, pit: NBI-Z=6, WLE-Z=4.5, p < 0.001; microvasculature: NBI-Z=7.3, WLE-Z=4.9, p < 0.001. This translated into a superior prediction of histology (Sn: NBI-Z: 88.9, WLE-Z: 71.9, p < 0.001). For the prediction of dysplasia, NBI-Z was superior to WLE-Z (chi(2)=10.3, p < 0.05). The overall kappa agreement among the five endoscopists for NBI-Z and WLE-Z, respectively, was 0.59 and 0.31 (p < 0.001). CONCLUSIONS: NBI-Z is superior to WLE-Z in the prediction of histology in BE, with good reproducibility. This novel imaging modality could be an important tool for surveillance of patients with BE.


Subject(s)
Barrett Esophagus/pathology , Esophagoscopy/methods , Esophagus/pathology , Image Enhancement , Adult , Aged , Aged, 80 and over , Barrett Esophagus/diagnosis , Esophagus/blood supply , Female , Humans , Image Enhancement/methods , Image Processing, Computer-Assisted , Light , Male , Middle Aged , Precancerous Conditions/diagnosis , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity
2.
Eur J Gastroenterol Hepatol ; 17(1): 65-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15647643

ABSTRACT

Hepatic venous thrombosis (Budd-Chiari) in evolution is a rare phenomenon and carries a high morbidity and mortality. We describe the case of a 39-year-old Bangladeshi lady who presented with severe abdominal pain secondary to a perforated duodenal ulcer and during her hospital admission developed an asymptomatic Budd-Chiari syndrome (BCS). Our report highlights the important role of an inflammatory focus, and how this process with an associated reactive thrombocytosis may act as a trigger for the development of BCS in an individual with predisposing risk factors. Our patient had been on the contraceptive pill, and was homozygous for the C677T mutation of 5,10-methylenetetrahydrofolate reductase, which results in hyperhomocysteinaemia. These pro-thrombotic risk factors were compounded by the thrombogenic potential of subsequent laparoscopic surgery, and resulted in an evolving thrombus that progressed into the inferior vena cava causing hepatic infarction. A particular feature of this case was the radiological demonstration of complete regression of the thrombus and the hepatic parenchymal changes, upon resolution of the inflammation and normalization of the platelet count. These changes occurred with oral anticoagulation as the only treatment modality, since our patient declined systemic thrombolysis. The demonstration of complete radiological resolution raises the question of how long one should continue oral anticoagulants and, indeed, whether in some instances a conservative approach may be the best management strategy for evolving BCS.


Subject(s)
Budd-Chiari Syndrome/etiology , Adult , Budd-Chiari Syndrome/diagnostic imaging , Budd-Chiari Syndrome/therapy , Duodenal Ulcer/complications , Female , Humans , Hyperhomocysteinemia/complications , Peptic Ulcer Perforation/complications , Prognosis , Risk Factors , Tomography, X-Ray Computed
3.
Mol Immunol ; 40(7): 451-6, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14568391

ABSTRACT

beta-Defensin peptides are known to be potent anti-bacterials with a wide spectrum of activity. They, therefore, represent an important aspect of innate immunity. In the present study, we have extended our understanding of the regulation of the beta-defensins in response to Helicobacter pylori (H. pylori) infection. We found elevated levels of hBD2 and hBD3 transcripts within gastric cells following infection. This was reflected by increased secretion of the corresponding peptide. The relative bactericidal potency of the beta-defensins was also assessed. Our findings show that hBD3 was the most potent peptide tested followed by hBD2 and hBD1. Relatively modest synergy between hBD1 and hBD2 was also noted. More importantly, we observed endogenous production of putative anti-microbial factors by infected gastric epithelial cells. Our study highlights the active participation of the epithelium in protection against potential pathogens.


Subject(s)
Helicobacter Infections/immunology , Helicobacter pylori/immunology , Host-Parasite Interactions/immunology , Humans , beta-Defensins/biosynthesis , beta-Defensins/genetics , beta-Defensins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL